Imaging Technology News (ITN) recently took home top honors for best technical content for its team coverage of the topic of gadolinium, which included a combination of print, video and social media, at the Jesse H. Neal Awards in New York City. The Neal Awards, sponsored by Connectiv, a division of the Software and Information Industry Association, are recognized as the Pulitzer Prize of the business press. The winners are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship.

May 29, 2019 — QT Ultrasound recently showcased its advanced ultrasound technology at the Acoustical Society of America (ASA) 177th meeting, May 13-17 in Louisville, Ky.

A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described the use of Konica Minolta’s Dynamic Digital Radiography (DDR) technology in the assessment of undifferentiated dyspnea.

Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016 despite screening recommendations, according to a new analysis. These numbers come despite U.S. Preventive Services Task Force (USPSTF) and American Society of Clinical Oncology (ASCO) screening recommendations.

Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S.

Accuray Radixact

While radiation therapy as a discipline is well into maturity, new technology advances continue to drive the field forward. The following is a roundup of some of the most significant products to launch or be introduced in the last 12 months.

 

Image-guided Radiation Therapy Systems

The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at The Ottawa Hospital (TOH, Ottawa, Ontario) by surprise. The medical center began acquiring the extra needed cancer treatment resources in 2009, when the hospital entered a partnership agreement with Elekta to reinforce its radiotherapy capacity with additional linear accelerators and software.

A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months earlier than radiologic imaging by detecting traces of tumor DNA in the blood after surgery. The test also identified patients most likely to relapse, both before and after chemotherapy.1 Results were published in the May issue of JAMA Oncology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now